As SARS-CoV-2 continues to spread in France, a thorough characterization of hospital care needs and of the trajectories of hospital
Continue reading »
Home »
Evidence of monoclonal antibodies effectively neutralizing SARS-CoV-2 variants
Evolving variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become a growing concern worldwide for their rapid transmission
Continue reading »
FDA authorizes use of Symbiotica COVID-19 Self-Collected Antibody Test System
The U.S. Food and Drug Administration today announced it has issued an emergency use authorization (EUA) for the Symbiotica COVID-19
Continue reading »
Research shows efficacy of early warning signals for disease emergence amid COVID-19
The coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread worldwide. To
Continue reading »
Proper choice of control group nullifies most observed genetic markers for severe COVID-19, study suggests
With over 127.8 million cases of coronavirus disease 2019 (COVID-19) already documented, and many more millions that have undoubtedly gone
Continue reading »
Corticosteroid therapy in pregnant women with COVID-19
The onset of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, which causes coronavirus disease 2019 (COVID-19), has led
Continue reading »
Virus-cell interaction may partly explain the higher infection rate of COVID-19
Bioengineering researchers at Lehigh University have identified a previously unknown interaction between receptors in human cells and the spike, or
Continue reading »
Study reveals heightened mortality and racial disparities for cancer patients diagnosed with COVID-19
The COVID-19 and Cancer Consortium (CCC19) published new findings in the Annals of Oncology, showing heightened mortality and racial disparities
Continue reading »
Protection against repeat SARS-CoV-2 infection about 80 percent
(HealthDay)—Protection against repeat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is about 80 percent but is lower among older
Continue reading »
Can vaccine evading SARS-CoV-2 variants be restricted by prioritized vaccine rollout?
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to disrupt global
Continue reading »